Recruiting

Observational Study

Sponsor:

National Institute of Allergy and Infectious Diseases (NIAID)

Code:

NCT07416201

Conditions

Down Syndrome

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Accepted

Study Details

Brief summary:

Background:

Down syndrome is a genetic disorder that can cause heart defects and other problems in the body. People with Down syndrome are more likely to have infections, autoimmunity, and blood diseases. Some may need surgery to treat congenital heart problems. During this surgery, doctors sometimes remove part of the thymus. The thymus is an organ that plays a role in immune function. People who have had part of their thymus removed may get sick more often than others do.

Objective:

This natural history study will gather data about how removing part of the thymus affects the health of people with Down syndrome.

Eligibility:

People aged 1 year and older with Down syndrome. The study will include both people who have, and those who have not had, surgery to remove part of their thymus. Healthy relatives are also needed.

Design:

Participants with Down syndrome will have clinic visits at least once a year for 15 years.

At each visit they will have a physical exam. They will give blood and stool samples. They will have tests of their heart and lung function.

Participants aged 18 years or older may have at least 1 imaging scan: They will lie on a table that slides into a donut-shaped machine. The machine uses X-rays to take pictures of the inside of the body.

Participants who have tissue samples collected from their bodies (biopsies) taken during the study may have extra tissue taken for research.

Healthy relatives will also have visits once a year for 15 years. They will only have a physical exam and provide blood and stool samples.

Conditions

Down Syndrome

Study ID

NCT07416201

Start date

Jun 23, 2026

Status verified date

Jul 10, 2026

Completion date

Nov 1, 2040

Anticipated

Primary completion date

May 1, 2040

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 1 - 70+

Healthy Volunteers: Accepted

  • INCLUSION CRITERIA:

In order to be eligible to participate in this study, an individual must meet all of the following criteria:

1\. Aged >=1 year.

2\. Willingness to allow storage of specimens and data for future research.

  • Additional Inclusion Criteria for Affected Participants

1. Documented T21 based on chromosomal karyotype test.
2. Ability of participant or LAR to provide informed consent.
  • Additional Inclusion Criteria for Unaffected Relatives

1. Ability of participant to provide informed consent or, for individuals <18 years of age, to provide informed assent as applicable.
2. Reside in the same household as the corresponding affected participant.

EXCLUSION CRITERIA:

An individual who meets any of the following criteria will be excluded from participation in this study:

1\. Any condition that, in the judgment of the investigator, may put the participant at undue risk or make them unsuitable for participation in the study.

Study Design

Enrollment

700 participants

Anticipated

Interventions and Outcome Measures

Arms

Trisomy 21 Participants

Participants aged >=1 year old who have T21

Unaffected Relative Participants

Participants aged >=1 year old who are related to a participant with T21

Primary outcome measure

  • Frequency of T21 individuals with laboratory evidence of autoantibodies [ Time Frame: Through end of study ]
  • Number and type of autoimmune manifestations/year [ Time Frame: Through end of study ]
  • Frequency of individuals with abnormal T and B cell counts and immunoglobulin serum levels [ Time Frame: Through end of study ]
  • Proportion of T21 individuals with malignancies by age group (compared to the general population), and type of malignancies [ Time Frame: Through end of study ]
  • Nature of infections (bacterial, viral, fungal, opportunistic pathogens) requiring hospitalization [ Time Frame: Through end of study ]
  • Incidence of severe infections requiring hospital admission (number of admissions/year; number of days of hospitalization/year) [ Time Frame: Through end of study ]

Central Contacts and Locations

Central contacts

Locations

National Institutes of Health Clinical Center

Recruiting

Bethesda, Maryland, United States, 20892

Contacts

NIH Clinical Center Office of Patient Recruitment (OPR)

800-411-1222ccopr@nih.gov

More Information

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Last update posted

Jul 16, 2026

Last verified

Jul 10, 2026

Keywords

  • Down Syndrome
  • Immunologic Deficiency Syndromes
  • THYMECTOMY

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by National Institute of Allergy and Infectious Diseases (NIAID) on 2026-07-16.